Erratum: Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: The DECAAF study (JAMA (2014) 311: 5 (498-506) DOI: 10.1001/jama.2014.3);Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: The DECAAF study

JAMA

Volumn 311, Issue 5, 2014, Pages 498-506

  Marrouche, Nassir F ^a   Wilber, David ^b   Hindricks, Gerhard ^c   Jais, Pierre ^d   Akoum, Nazem ^a   Marchlinski, Francis ^e   Kholmovski, Eugene ^a   Burgon, Nathan ^a   Hu, Nan ^a   Mont, Lluis ^f   Deneke, Thomas ^g   Duytschaever, Mattias ^h   Neumann, Thomas ⁱ   Mansour, Moussa ^j   Mahnkopf, Christian ^k   Herweg, Bengt ^l   Daoud, Emile ^m   Wissner, Erik ⁿ   Bansmann, Paul ^o   Brachmann, Johannes ^k  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d BORDEAUX UNIVERSITY HOSPITAL   (France)

^e HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF BARCELONA   (Spain)

^g RUHR UNIVERSITY BOCHUM   (Germany)

^h GHENT UNIVERSITY HOSPITAL   (Belgium)

ⁱ KERCKHOFF HEART CENTER   (Germany)

^j MASSACHUSETTS GENERAL HOSPITAL   (United States)

^k KLINIKUM COBURG   (Germany)

^l UNIVERSITY OF SOUTH FLORIDA   (United States)

^m OHIO STATE UNIVERSITY   (United States)

ⁿ DEPARTMENT OF CARDIOLOGY   (Germany)

^o Kinderklinik   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

ADULT; AMBULATORY MONITORING; ANALYSIS OF COVARIANCE; ARTICLE; ATRIAL FIBRILLATION CATHTER ABLATION; ATRIAL TISSUE FIBROSIS; AUSTRALIA; CARVOTRICUSPID ISTHMUS; CATHETER ABLATION; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DELAYED DIAGNOSIS; DEMOGRAPHY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ELECTROCARDIOGRAPHY; ESOPHAGUS INJURY; EUROPE; FEASIBILITY STUDY; FEMALE; FEMORAL ARTERIAL VENOUS FISTULA; FEMORAL HEMATOMA; FEMUR MALFORMATION; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART TAMPONADE; HUMAN; HUMAN TISSUE; INCIDENCE; INFLAMMATION; ISCHEMIC HEART DISEASE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PAROXYSMAL HEART ATRIUM FIBRILLATION; PREDICTION; PRIORITY JOURNAL; PULMONARY VEIN ISOLATION; PULMONARY VEIN NARROWING; RECURRENT DISEASE; RISK FACTOR; STATISTICS; UNITED STATES;

AGED; ATRIAL FIBRILLATION; CATHETER ABLATION; FEMALE; FIBROSIS; HEART ATRIA; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; RISK; TREATMENT OUTCOME;

EID: 84893558187     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.14371     Document Type: Erratum

References (36)

1. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res. 2002;54(2):230-246. (Pubitemid 34327903)
2. Smith JG, Newton-Cheh C, Almgren P, et al. Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation. J Am Coll Cardiol. 2010;56(21):1712-1719.
3. Morillo CA, Klein GJ, Jones DL, Guiraudon CM. Chronic rapid atrial pacing: structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation. 1995;91(5):1588-1595.
4. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation. 1995;92(7):1954-1968.
5. Wazni OM, Marrouche NF, Martin DO, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA. 2005;293(21):2634-2640. (Pubitemid 40744248)
6. Jaïs P, Cauchemez B, Macle L, et al. Catheter ablation versus antiarrhytmic drugs for atrial fibrillation: the A4 study [published correction appears in Circulation. 2009;120(10):e83]. Circulation. 2008;118(24):2498-2505.
7. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100(19):1992-2002. (Pubitemid 29529292)
8. Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol. 2000;36(6):1985-1991.
9. Perin EC, Silva GV, Sarmento-Leite R, et al. Assessing myocardial viability and infarct transmurality with left ventricular electromechanical mapping in patients with stable coronary artery disease: validation by delayed-enhancement magnetic resonance imaging. Circulation. 2002;106(8):957-961. (Pubitemid 34925330)
10. Peters DC, Wylie JV, Hauser TH, et al. Detection of pulmonary vein and left atrial scar after catheter ablation with three-dimensional navigator-gated delayed enhancement MR imaging: initial experience. Radiology. 2007;243(3):690-695. (Pubitemid 46799421)
11. McGann CJ, Kholmovski EG, Oakes RS, et al. New magnetic resonance imaging-based method for defining the extent of left atrial wall injury after the ablation of atrial fibrillation. J Am Coll Cardiol. 2008;52(15):1263-1271.
12. Oakes RS, Badger TJ, Kholmovski EG, et al. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation. 2009;119(13):1758- 1767.
13. Akoum N, Daccarett M, McGann C, et al. Atrial fibrosis helps select the appropriate patient and strategy in catheter ablation of atrial fibrillation: a DE-MRI guided approach. J Cardiovasc Electrophysiol. 2011;22(1):16-22.
14. Calkins H, Kuck KH, Cappato R, et al; Heart Rhythm Society Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints and research trial design. Heart Rhythm. 2012;9(4):632-696, e21.
15. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. 2nd ed. New York, NY: Wiley; 2002.
16. Allessie MA. Atrial electrophysiologic remodeling: another vicious circle? J Cardiovasc Electrophysiol. 1998;9(12):1378-1393. (Pubitemid 28565136)
17. Everett TH IV, Olgin JE. Atrial fibrosis and the mechanisms of atrial fibrillation. Heart Rhythm. 2007;4(3)(suppl):S24-S27.
18. Li D, Fareh S, Leung TK, Nattel S. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation. 1999;100(1):87-95. (Pubitemid 29297945)
19. Kainuma S, Masai T, Yoshitatsu M, et al. Advanced left-atrial fibrosis is associated with unsuccessful maze operation for valvular atrial fibrillation. Eur J Cardiothorac Surg. 2011;40(1):61-69.
20. Platonov PG, Mitrofanova LB, Orshanskaya V, Ho SY. Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. J Am Coll Cardiol. 2011;58(21):2225-2232.
21. Mahnkopf C, Badger TJ, Burgon NS, et al. Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation. Heart Rhythm. 2010;7(10):1475-1481.
22. Thomas MC, Dublin S, Kaplan RC, et al. Blood pressure control and risk of incident atrial fibrillation. Am J Hypertens. 2008;21(10):1111-1116.
23. Conen D, Tedrow UB, Koplan BA, Glynn RJ, Buring JE, Albert CM. Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation. 2009;119(16):2146-2152.
24. Bertaglia E, Stabile G, Pappone A, et al. Updated national multicenter registry on procedural safety of catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2013;24(10):1069-1074.
25. Dagres N, Hindricks G, Kottkamp H, et al. Complications of atrial fibrillation ablation in a high-volume center in 1,000 procedures: still cause for concern? J Cardiovasc Electrophysiol. 2009;20(9):1014-1019.
26. Flaker GC, Fletcher KA, Rothbart RM, Halperin JL, Hart RG; Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. Clinical and echocardiographic features of intermittent atrial fibrillation that predict recurrent atrial fibrillation. Am J Cardiol. 1995;76(5):355-358.
27. Camm AJ, Kirchhof P, Lip GY, et al; European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31(19):2369- 2429.
28. Cosedis Nielsen J, Johannessen A, Raatikainen P, et al. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N Engl J Med. 2012;367(17):1587-1595.
29. Kobza R, Hindricks G, Tanner H, et al. Late recurrent arrhythmias after ablation of atrial fibrillation: incidence, mechanisms, and treatment. Heart Rhythm. 2004;1(6):676-683. (Pubitemid 40028773)
30. Badger TJ, Daccarett M, Akoum NW, et al. Evaluation of left atrial lesions after initial and repeat atrial fibrillation ablation: lessons learned from delayed-enhancement MRI in repeat ablation procedures. Circ Arrhythm Electrophysiol. 2010;3(3):249-259.
31. Wilber DJ, Pappone C, Neuzil P, et al; ThermoCool AF Trial Investigators. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA. 2010;303(4):333-340.
32. Haïssaguerre M, Hocini M, Sanders P, et al. Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias. J Cardiovasc Electrophysiol. 2005;16(11):1138-1147.
33. Oral H, Scharf C, Chugh A, et al. Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation. 2003;108(19):2355-2360. (Pubitemid 37413542)
34. Ganesan AN, Shipp NJ, Brooks AG, et al. Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis. J Am Heart Assoc. 2013;2(2):e004549.
35. Gaita F, Caponi D, Scaglione M, et al. Long-term clinical results of 2 different ablation strategies in patients with paroxysmal and persistent atrial fibrillation. Circ Arrhythm Electrophysiol. 2008;1(4):269-275.
36. Coyne KS, Paramore C, Grandy S, Mercader M, Reynolds M, Zimetbaum P. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value Health. 2006;9(5):348-356. (Pubitemid 44337788)